Ireland
--:--IST
Latest
Clinical Trials in Canada / NCT05411549
Enrolling by invitation Not applicable

The Role of a Mediterranean Diet in Patients With Endometriosis: a Feasibility Trial

NCT05411549 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2023-08-22
Last updated
2026-06-08

Condition(s) studied

Endometriosis

Investigational drug(s) / intervention(s)

Diet Modification to Adopt Mediterranean Diet

Diet Modification to Adopt Mediterranean Diet: Participants enrolled in group 1 will be counselled by a dietician and asked to adopt a Mediterranean diet for a 12-week period from counselling. Participants will complete a series of Mediterranean Diet Adherence Score, pain questionnaires as well as quality of life questionnaires (EPH-30, SF-36, GIQLI) which have been previously validated. Participants in this group will give a baseline and final visit blood sample and stool samples to assess inflammation biomarkers as well as gut microflora.

Study summary

This study aims to test if making changes to diet can affect the pelvic pain associated with endometriosis. One group will follow a Mediterranean diet for 12 weeks while the control group will continue with their current diet. We will be looking at the feasibility of a larger-scale trial as well as self-reported quality of life and self-reported pain using standardized questionnaires, that have previously been used and validated, and assessing how this diet affects biomarkers associated with endometriosis and inflammation. Further, we will test how this change in diet affects the gut microbe flora.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
45 Years
Healthy volunteers
No
Inclusion Criteria: * Identified female at birth * aged 18-45 * diagnosed with endometriosis (radiologically (ultrasound or magnetic resonance imaging (MRI)) or surgically confirmed diagnosis of endometriosis) * Able and willing to provide written consent to participate in the study. Exclusion Criteria: * History of or diagnosis of gynecologic or GI malignancy * Post-menopausal * Currently pregnant or lactating * Dietary restrictions due to medical conditions (e.g., Celiac disease, allergies) * People who are already following a formal anti-inflammatory diet.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
McMaster University Hamilton Ontario

More McMaster University trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05411549 on ClinicalTrials.gov ↗ ← All trials in Canada